DAITO PHARMACEUTICAL CO.,LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,502 JPY | +0.08% |
|
-0.64% | +31.34% |
| Apr. 12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
| Apr. 12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
ETFs positioned on Daito Pharmaceutical Co.,Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 15 M€ | +11.75% | ||
| 0.01% | 18 M€ | +16.15% | - | |
| 0.01% | 144,586 M€ | +16.55% | ||
| 0.01% | 66,066 M€ | +16.86% | - | |
| 0.01% | 20,721 M€ | +15.40% | - |
Daito Pharmaceutical Co., Ltd. is a Japan-based company mainly engaged in the pharmaceutical ingredients and formulation business, as well as healthy food. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Final dividend
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,502
JPY
Average target price
3,155
JPY
Spread / Average Target
+26.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +31.34% | 252M | |
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +14.32% | 13.79B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
- Stock Market
- Equities
- 4577 Stock
- Funds and ETFs Daito Pharmaceutical Co.,Ltd.
